Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The approval of injectable semaglutide for adolescents aged 12 and older in 2022 established a precedent for GLP-1-based weight management in younger patients, and an oral option could substantially change the treatment calculus for this population
Rubbing can cause irritation and may affect absorption
If oral semaglutide is considered to be similarly safe and effective relative to currently available treatments for T2DM at a submitted price of $6.97 per tablet (daily cost of $6.97), oral semaglutide is more costly than all sodium-glucose cotransporter-2-based products ($2.45 to $3.24), dipeptidyl peptidase-4-based products ($2.20 to $3.47), and, depending on dose, some GLP-1 receptor agonist-based products, ($3.55 to $9.34)
Most patients begin at microdose levels and advance to standard therapeutic ranges based on their tolerance and weight-loss progress
demand
No, its a normal part of early treatment
US$ 20.51
US$ 26.45
US$ 22.34
